Skip to main content
. 2021 Mar 24;11(3):e046529. doi: 10.1136/bmjopen-2020-046529

Figure 4.

Figure 4

Mean and 95% CI values for the prevalence of liver fibrosis (≥F2) using MRE according to risk factors. *Abnormal LFT: AST>33 U/L and/or ALT >38 U/L. ALT, alanine aminotransferase; AST, aspartate transaminase; LFT, liver function test; MRE, magnetic resonance elastography; NAFLD, non-alcoholic fatty liver disease.